Hosted on MSN
Astra plans full New York listing: Move fuels fears pharma giant could abandon UK altogether
AstraZeneca is to launch a direct listing on the New York stock exchange in a blow to the City that will raise fears that it may eventually abandon the London market. The move beefs up the £170billion ...
AstraZeneca is to launch a direct listing on the New York stock exchange in a blow to the City that will raise fears that it may eventually abandon the London market. The move beefs up the £170billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback